Atlas Trials

Evaluation of Ultrasensitive Chromosomal Aneuploidy Detection for Detecting Minimal Residual Disease in Multiple Myeloma

Clinical trial NCT04122092 · UNKNOWN

Trial details

NCT number
NCT04122092
Sponsor
Shanghai Changzheng Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2019-10-20
Primary completion
2021-10-20
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.